[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572499":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":12,"centralContacts":24,"locations":30,"responsibleParty":47,"collaborators":12,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":57,"eligibilityCriteria":58,"healthyVolunteers":53,"sex":59,"minAge":60,"maxAge":12,"enrollmentInfo":61,"targetDuration":12,"studyType":64,"phases":65,"briefSummary":67,"conditions":68,"keywords":70,"overallStatus":33,"whyStopped":12,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Linkoeping University","OTHER_GOV",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual care group","NO_INTERVENTION","Patients in the usual care group will receive usual care.",null,{"label":14,"type":15,"description":12,"interventionNames":16},"ReDS-guided heart failure management group","EXPERIMENTAL",[17],"Behavioral: ReDS-guided heart failure management program",[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"BEHAVIORAL","ReDS-guided heart failure management program","Remote dielectric sensing (ReDS) system (Sensible Medical Innovations Ltd., Netanya, Israel) is a novel electromagnetic energy-based technology that accurately quantifies changes in lung fluid concentration non-invasively.\n\nPatients in the intervention group will receive a three-month, ReDS-guided heart failure management program in addition to usual care.\n\nThe program, led by nurses, will integrate algorithms for diuretic use, a structured follow-up schedule, and self-care support tailored to pulmonary fluid levels assessed by ReDS.",[14],[25],{"name":26,"role":27,"phone":28,"phoneExt":12,"email":29},"Naoko Perkiö Kato, PhD","CONTACT","+46 (0)11-36 31 17","naoko.perkio.kato@liu.se",[31],{"facility":32,"status":33,"city":34,"state":12,"zip":12,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Primary care center Centrum Flen","RECRUITING","Flen","Sweden","SE",{"type":38,"coordinates":39},"Point",[40,41],16.58781,59.05834,{"lat":41,"lon":40},[44],{"name":45,"role":27,"phone":46,"phoneExt":12,"email":29},"Naoko Perkiö Kato, RN, PhD","+46 11-36 31 17",{"type":48,"investigatorFullName":49,"investigatorTitle":50,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"PRINCIPAL_INVESTIGATOR","Naoko Perkiö Kato","Associate Professor","100572499","effect-of-non-invasive-lung-fluid-monitoring-for-heart-failure-management-in-primary-care-100572499",false,"NCT06734065","Effect of Non-Invasive Lung Fluid Monitoring for Heart Failure Management in Primary Care","Effect of Non-Invasive Lung Fluid Monitoring Using ReDS Technology for Heart Failure Management in Primary Care Settings: A Randomized Controlled Trial","LiLAC-HF","Inclusion Criteria:\n\n* Age ≥ 18 years, there is no upper age limit\n* Diagnosed with heart failure regardless of left ventricular ejection fraction\n* Having New York Heart Association (NYHA) Class III\u002FIV irrespective of prior hospitalisation for heart failure, or NYHA II with a history of at least one hospitalisation for heart failure within the previous 12 months\n* Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) within 12 months: (a) ≥450 pg\u002Fml for patients under 50 years; (b) ≥900 pg\u002Fml for patients aged 50-75 years; (c) ≥1800 pg\u002Fml for patients over 75 years.\n\nExclusion Criteria:\n\n* NYHA I\n* Life expectancy \\\u003C6 months\n* Physical characteristics that prevented use of the ReDS (body mass index \\\u003C 22 or \\>39, and height less than 155 cm or higher than 195 cm)\n* Implantation of a left ventricular assist device or cardiac transplantation.","ALL","18 Years",{"count":62,"type":63},330,"ESTIMATED","INTERVENTIONAL",[66],"NA","Remote dielectric sensing (ReDS) technology offers a non-invasive method for assessing lung congestion. This randomized controlled trial aims to evaluate the effectiveness and processes of the ReDS-guided heart failure management program in primary care settings for patients with heart failure.",[69],"Heart Failure",[71,72,73,74,75,76],"Heart failure","Primary care","Nursing","Monitoring","Self-care","Community","2025-04-23",{"date":79,"type":80},"2025-04-27","ACTUAL",{"date":82,"type":80},"2025-04-16",{"date":84,"type":63},"2030-12",{"name":5,"class":6},1]